Documents & Downloads

VHR-IN-8

VHR Phosphatase Inhibitor

VHR-IN-8 is a selective inhibitor of vaccinia H1-related phosphatase (VHR) with an IC50 value of 2.4 μM. It demonstrates significant potential in the study of cervical cancer, providing valuable insights into the molecular mechanisms underlying tumor progression. This compound serves as a critical tool for researchers investigating the role of phosphatases in cancer biology and therapeutic development.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	1146616-19-4
Applications	VHR Phosphatase Inhibitor
Formula	C₂₅H₂₄N₄O₇S₄
Molecular Weight	620.74
SMILES	O=S(C(C=C1)=CC=C1C2=NN(C3=CC=CC=C3)C=C2/C=C4C(N(C(S/4)=S)CCS(=O)(O)=O)=O)(N5CCOCC5)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.